Endometrioid Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Managements.
Ricotta G, Maulard A, Candiani M, Scherrier S, Genestie C, Pautier P, Leary A, Chargari C, Mangili G, Morice P, Gouy S.
Ann Surg Oncol. 2022 Sep;29(9):5894-5903. doi: 10.1245/s10434-022-11893-7. Epub 2022 May 19.
Endometriosis-associated cancer.
Guidozzi F.
Climacteric. 2021 Dec;24(6):587-592. doi: 10.1080/13697137.2021.1948994. Epub 2021 Jul 16.
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, Chen LM, Cristea M, DeRosa M, Eisenhauer EL, Gershenson DM, Gray HJ, Grisham R, Hakam A, Jain A, Karam A, Konecny GE, Leath CA, Liu J, Mahdi H, Martin L, Matei D, McHale M, McLean K, Miller DS, O'Malley DM, Percac-Lima S, Ratner E, Remmenga SW, Vargas R, Werner TL, Zsiros E, Burns JL, Engh AM.
J Natl Compr Canc Netw. 2021 Feb 2;19(2):191-226. doi: 10.6004/jnccn.2021.0007.
Ovarian cancer: epidemiology and risk factors.
La Vecchia C.
Eur J Cancer Prev. 2017 Jan;26(1):55-62. doi: 10.1097/CEJ.0000000000000217.
Intracystic endometrioid borderline tumor.
El Hajj H, Narducci F, McCluggage G, Pasquesoone C.
Int J Gynecol Cancer. 2023 Oct 2;33(10):1663-1665. doi: 10.1136/ijgc-2022-004151.
A rare mixed ovarian tumor associating borderline endometrioid component and borderline serous component.
Hammouda SB, Njima M.
Pan Afr Med J. 2022 Jan 26;41:73. doi: 10.11604/pamj.2022.41.73.30418. eCollection 2022.
Brenner Borderline Ovarian Tumor: A Case Series and Literature Review.
Ricotta G, Maulard A, Genestie C, Pautier P, Leary A, Chargari C, Candiani M, Morice P, Gouy S.
Ann Surg Oncol. 2021 Oct;28(11):6714-6720. doi: 10.1245/s10434-021-09879-y. Epub 2021 Mar 25.
Mucinous Ovarian Tumors.
Mills AM, Shanes ED.
Surg Pathol Clin. 2019 Jun;12(2):565-585. doi: 10.1016/j.path.2019.01.008.
Comparative study of endometrioid borderline ovarian tumor with and without endometriosis.
Zhang W, Jia S, Xiang Y, Yang J, Jia C, Leng J.
J Ovarian Res. 2018 Aug 11;11(1):67. doi: 10.1186/s13048-018-0440-x.
PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis.
Yun BS, Won S, Kim JH, Lee N, Kim M, Kim MK, Kim ML, Jung YW, Kim JY, Seong SJ, Shin E.
J Ovarian Res. 2022 Apr 6;15(1):41. doi: 10.1186/s13048-022-00975-5.
